Effects of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients

Table 1 Comparison of clinical baseline data

Factor	Group A, n = 33	Group B, n = 37	P value
Age in yr
≥ 60	13	17	0.580
< 60	20	20
Sex
Male	22	35	0.447
Female	11	12
Course of disease in yr
≥ 5	19	20	0.767
< 5	14	17
BMI in kg/m2
≥ 30	25	30	0.587
< 30	8	7
History of hypertension
Yes	8	10	0.790
No	25	27
History of smoking
Yes	22	35	0.447
No	11	12

BMI: Body mass index.